Granted Patent
Utility
US 6,506,572 · App. 09/935,772
Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
Inventors:
Elfi Biedermann, Rolf Eisenburger, Max Hasmann, Roland Loser, Benno Rattel, Friedemann Reiter, Barbara Schein, Isabel Schemainda, Michael Schulz, Klaus Seibel, Klaus Vogt, Katja Wosikowski
Patented Case
View Patent ↗
Granted: Jan 14, 2003
Filed: Aug 23, 2001
Inventors
Elfi Biedermann
Rolf Eisenburger
Max Hasmann
Roland Loser
Benno Rattel
Friedemann Reiter
Barbara Schein
Isabel Schemainda
Michael Schulz
Klaus Seibel
Klaus Vogt
Katja Wosikowski
Assignee (at issue)
Klinge Pharma GmbH
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.